Beam Therapeutics Inc. (BMV:BEAM)
Mexico · Delayed Price · Currency is MXN 383.00
-20.00 (-4.96%)
At close: Jul 30, 2025
Intra-Cellular Therapies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Net Income | -387.34 | -376.74 | -132.53 | -289.09 | -370.64 | -194.59 | Upgrade |
Depreciation & Amortization | 22.02 | 21.93 | 20.01 | 14.15 | 7.45 | 4.74 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 154.95 | 5.65 | Upgrade |
Loss (Gain) From Sale of Investments | -7.22 | -8.67 | -11.15 | -29.61 | -17.77 | -0.4 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | 25.5 | - | - | Upgrade |
Stock-Based Compensation | 118.06 | 120.66 | 98.65 | 84.32 | 43.57 | 15.38 | Upgrade |
Other Operating Activities | 0.83 | 5.8 | -7.72 | -34.37 | 4.91 | 68.14 | Upgrade |
Change in Accounts Receivable | - | - | -0.15 | 300 | -300 | - | Upgrade |
Change in Accounts Payable | 4.32 | 1.81 | -7.58 | 2.37 | 0.82 | 0.06 | Upgrade |
Change in Unearned Revenue | -37.08 | -36.52 | -159.56 | -35.92 | 348.16 | - | Upgrade |
Change in Other Net Operating Assets | -64.97 | -75.51 | 50.83 | -14.83 | 62.28 | 5.29 | Upgrade |
Operating Cash Flow | -351.38 | -347.25 | -149.2 | 22.53 | -66.27 | -95.74 | Upgrade |
Capital Expenditures | -9.57 | -8.95 | -33.73 | -48.95 | -46.81 | -16.36 | Upgrade |
Cash Acquisitions | - | - | - | - | 0.62 | -0.75 | Upgrade |
Investment in Securities | 122.96 | 193.95 | 105.57 | -412.39 | -247.95 | -83.02 | Upgrade |
Investing Cash Flow | 113.38 | 185.01 | 71.84 | -461.34 | -294.14 | -100.12 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 3.27 | Upgrade |
Long-Term Debt Repaid | - | -0.49 | -2.25 | -2.29 | -2.12 | -1.57 | Upgrade |
Net Debt Issued (Repaid) | -0.31 | -0.49 | -2.25 | -2.29 | -2.12 | 1.7 | Upgrade |
Issuance of Common Stock | 478.53 | 8.22 | 279.33 | 114.07 | 767.08 | 322.68 | Upgrade |
Other Financing Activities | - | - | -0.63 | -0.19 | -8.82 | -2.06 | Upgrade |
Financing Cash Flow | 478.22 | 7.74 | 276.45 | 111.59 | 756.14 | 322.32 | Upgrade |
Net Cash Flow | 240.22 | -154.5 | 199.09 | -327.22 | 395.73 | 126.46 | Upgrade |
Free Cash Flow | -360.96 | -356.19 | -182.93 | -26.42 | -113.08 | -112.1 | Upgrade |
Free Cash Flow Margin | -567.74% | -560.77% | -48.43% | -43.38% | -218.11% | -467075.00% | Upgrade |
Free Cash Flow Per Share | -4.30 | -4.33 | -2.37 | -0.38 | -1.76 | -2.40 | Upgrade |
Cash Interest Paid | 0.02 | 0.03 | 0.16 | 0.38 | 0.57 | 0.56 | Upgrade |
Levered Free Cash Flow | -185.9 | -156.52 | -50.36 | 138.32 | -335.34 | -12.67 | Upgrade |
Unlevered Free Cash Flow | -185.9 | -156.52 | -50.36 | 138.32 | -335.34 | -12.67 | Upgrade |
Change in Net Working Capital | 47.21 | 30.43 | 24.98 | -300.35 | 191.1 | -66.55 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.